Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Hubacek

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Atherosclerosis|November 2, 2001
Angiotensin converting enzyme gene--a candidate gene for addiction to smoking?J A Hubacek, J Pitha, Z Skodova, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conservedJ A Hubacek, C Büchler, C Aslanidis, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 14, 1999
(TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemiaJ A Hubacek, H Pistulková, Z Valenta, et al.
Experimental and Clinical Cardiology|April 30, 2010
Low birth weight, apolipoprotein B Xba I polymorphism and hypercholesterolemia in childhoodJ A Hubacek, H Pistulková, Z Skodová, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2014
The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE studyJ A Hubacek, A Peasey, R Kubinova, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 26, 2022
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech populationJ A Hubacek, T Philipp, V Adamkova, et al.
Clinical Genetics|July 4, 2018
Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humansJ A Hubacek, M Jirsa, M Bobak, et al.
Annals of Clinical Biochemistry|July 27, 2001
Association between apolipoprotein B promotor haplotypes and cholesterol statusJ A Hubacek, H Pistulková, Z Skodová, et al.
Clinical Biochemistry|January 3, 2006
APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohortJ A Hubacek, Z Skodová, V Adámková, et al.
Clinical Genetics|February 27, 2004
The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarctionJ A Hubacek, Z Skodová, V Adámková, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Atherosclerosis|November 2, 2001
Angiotensin converting enzyme gene--a candidate gene for addiction to smoking?J A Hubacek, J Pitha, Z Skodova, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conservedJ A Hubacek, C Büchler, C Aslanidis, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 14, 1999
(TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemiaJ A Hubacek, H Pistulková, Z Valenta, et al.
Experimental and Clinical Cardiology|April 30, 2010
Low birth weight, apolipoprotein B Xba I polymorphism and hypercholesterolemia in childhoodJ A Hubacek, H Pistulková, Z Skodová, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2014
The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE studyJ A Hubacek, A Peasey, R Kubinova, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 26, 2022
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech populationJ A Hubacek, T Philipp, V Adamkova, et al.
Clinical Genetics|July 4, 2018
Aldehyde dehydrogenase 2 polymorphism affects the outcome of methanol poisoning in exposed humansJ A Hubacek, M Jirsa, M Bobak, et al.
Annals of Clinical Biochemistry|July 27, 2001
Association between apolipoprotein B promotor haplotypes and cholesterol statusJ A Hubacek, H Pistulková, Z Skodová, et al.
Clinical Biochemistry|January 3, 2006
APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohortJ A Hubacek, Z Skodová, V Adámková, et al.
Clinical Genetics|February 27, 2004
The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarctionJ A Hubacek, Z Skodová, V Adámková, et al.
Pageof 6